Evogene (EVGN) Ratios
Evogene Ratios
IL:EVGN's free cash flow for Q2 2026 was $-2.11M. For the 2026 fiscal year, IL:EVGN's free cash flow was decreased by $-9.29K and operating cash flow was $-2.10M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.54 | 1.15 | 4.96 | 6.71 | 8.27 |
| Quick Ratio | 4.48 | 1.06 | 4.95 | 6.61 | 8.25 |
| Cash Ratio | 3.76 | 0.82 | 2.99 | 5.15 | 4.70 |
| Solvency Ratio | -0.91 | -0.60 | -0.95 | -1.13 | -1.98 |
| Operating Cash Flow Ratio | -3.92 | -1.05 | -3.11 | -4.21 | -3.61 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -1.90 | -25.30 | -26.79 | -25.50 |
| Net Current Asset Value | $ 7.56M | $ -3.44M | $ 12.05M | $ 16.41M | $ 44.01M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.32 | 0.23 | 0.21 | 0.03 |
| Debt-to-Equity Ratio | -26.80 | -8.87 | 0.95 | 0.43 | 0.05 |
| Debt-to-Capital Ratio | 1.04 | 1.13 | 0.49 | 0.30 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.46 | 0.27 | 0.00 |
| Financial Leverage Ratio | -244.46 | -27.47 | 4.24 | 2.01 | 1.42 |
| Debt Service Coverage Ratio | -6.45 | -1.27 | -22.63 | -24.02 | -20.19 |
| Interest Coverage Ratio | -7.42 | -151.65 | -154.33 | -123.30 | -78.14 |
| Debt to Market Cap | 0.00 | 0.97 | 0.29 | 0.38 | 0.00 |
| Interest Debt Per Share | 0.52 | 2.28 | 2.56 | 2.95 | 0.07 |
| Net Debt to EBITDA | 0.88 | 0.18 | 0.40 | 0.63 | 1.07 |
| Profitability Margins | |||||
| Gross Profit Margin | -6.25% | 57.32% | 24.80% | -105.91% | -222.69% |
| EBIT Margin | -346.25% | -264.39% | -457.73% | -1761.97% | -3228.92% |
| EBITDA Margin | -316.56% | -239.63% | -411.42% | -1607.94% | -2988.71% |
| Operating Profit Margin | -364.24% | -337.17% | -467.93% | -1774.03% | -3386.02% |
| Pretax Profit Margin | -350.32% | -265.52% | -460.76% | -1776.36% | -3272.26% |
| Net Profit Margin | -220.22% | -295.59% | -423.39% | -1590.33% | -2988.49% |
| Continuous Operations Profit Margin | -350.35% | -265.68% | -460.18% | -1781.73% | -3273.66% |
| Net Income Per EBT | 62.86% | 111.32% | 91.89% | 89.53% | 91.33% |
| EBT Per EBIT | 96.18% | 78.75% | 98.47% | 100.13% | 96.64% |
| Return on Assets (ROA) | -42.33% | -41.35% | -46.73% | -47.46% | -36.42% |
| Return on Equity (ROE) | 10347.56% | 1136.11% | -198.12% | -95.37% | -51.80% |
| Return on Capital Employed (ROCE) | -84.53% | -88.83% | -59.77% | -58.84% | -45.36% |
| Return on Invested Capital (ROIC) | -81.04% | -58.53% | -57.47% | -56.85% | -44.12% |
| Return on Tangible Assets | -42.33% | -59.58% | -62.95% | -63.44% | -45.49% |
| Earnings Yield | -97.96% | -154.73% | -62.22% | -92.34% | -4.13% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.80 | 3.75 | 7.01 | 2.09 | 0.79 |
| Payables Turnover | 6.41 | 1.94 | 2.38 | 3.33 | 2.05 |
| Inventory Turnover | 19.50 | 1.31 | 55.80 | 6.09 | 32.62 |
| Fixed Asset Turnover | 1.46 | 1.31 | 1.64 | 0.41 | 0.22 |
| Asset Turnover | 0.19 | 0.14 | 0.11 | 0.03 | 0.01 |
| Working Capital Turnover Ratio | 0.51 | 0.37 | 0.19 | 0.04 | 0.02 |
| Cash Conversion Cycle | 92.29 | 187.96 | -95.05 | 125.24 | 294.01 |
| Days of Sales Outstanding | 130.54 | 97.32 | 52.03 | 174.98 | 460.76 |
| Days of Inventory Outstanding | 18.72 | 278.96 | 6.54 | 59.90 | 11.19 |
| Days of Payables Outstanding | 56.97 | 188.33 | 153.63 | 109.64 | 177.94 |
| Operating Cycle | 149.26 | 376.28 | 58.57 | 234.88 | 471.95 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.71 | -3.46 | -4.72 | -5.75 | -0.61 |
| Free Cash Flow Per Share | -1.73 | -3.57 | -4.89 | -6.03 | -0.62 |
| Dividend Paid and CapEx Coverage Ratio | -100.01 | -31.47 | -27.49 | -20.22 | -34.31 |
| Capital Expenditure Coverage Ratio | -100.01 | -31.47 | -27.49 | -20.22 | -34.31 |
| Operating Cash Flow Coverage Ratio | -6.14 | -1.53 | -1.88 | -1.98 | -9.31 |
| Operating Cash Flow to Sales Ratio | -3.50 | -3.53 | -3.83 | -14.14 | -26.71 |
| Free Cash Flow Yield | -157.44% | -190.79% | -58.27% | -86.14% | -3.80% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.02 | -0.65 | -1.61 | -1.08 | -24.20 |
| Price-to-Sales (P/S) Ratio | 2.25 | 1.91 | 6.80 | 17.22 | 723.25 |
| Price-to-Book (P/B) Ratio | -105.63 | -7.34 | 3.18 | 1.03 | 12.54 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.64 | -0.52 | -1.72 | -1.16 | -26.31 |
| Price-to-Operating Cash Flow Ratio | -0.64 | -0.54 | -1.78 | -1.22 | -27.08 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 0.01 | 0.08 | -0.00 | -3.87 |
| Enterprise Value Multiple | 0.17 | -0.62 | -1.25 | -0.44 | -23.13 |
| Enterprise Value | -2.10M | 8.23M | 29.11M | 11.80M | 642.97M |
| EV to EBITDA | 0.17 | -0.62 | -1.25 | -0.44 | -23.13 |
| EV to Sales | -0.54 | 1.48 | 5.16 | 7.04 | 691.36 |
| EV to Free Cash Flow | 0.15 | -0.40 | -1.30 | -0.47 | -25.15 |
| EV to Operating Cash Flow | 0.16 | -0.42 | -1.35 | -0.50 | -25.89 |
| Tangible Book Value Per Share | 1.52 | 0.46 | 3.40 | 5.01 | 1.18 |
| Shareholders’ Equity Per Share | -0.01 | -0.25 | 2.64 | 6.78 | 1.31 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.49 | 0.98 | 1.23 | 0.41 | 0.02 |
| Net Income Per Share | -1.08 | -2.89 | -5.23 | -6.46 | -0.68 |
| Tax Burden | 0.63 | 1.11 | 0.92 | 0.90 | 0.91 |
| Interest Burden | 1.01 | 1.00 | 1.01 | 1.01 | 1.01 |
| Research & Development to Revenue | 2.07 | 2.24 | 3.21 | 10.46 | 20.89 |
| SG&A to Revenue | 1.50 | 1.61 | 1.54 | 5.61 | 10.04 |
| Stock-Based Compensation to Revenue | 0.17 | 0.32 | 0.33 | 0.71 | 2.81 |
| Income Quality | 0.95 | 1.09 | 0.83 | 0.79 | 0.82 |
Currency in USD